Literature DB >> 9624300

New therapies for chronic obstructive pulmonary disease.

P J Barnes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9624300      PMCID： PMC1758707          DOI： 10.1136/thx.53.2.137

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  93 in total

Review 1.  The role of pulmonary surfactant in obstructive airways disease.

Authors:  J Hohlfeld; H Fabel; H Hamm
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

Review 2.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

3.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.

Authors:  V M Keatings; A Jatakanon; Y M Worsdell; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1997-02       Impact factor: 21.405

4.  Histamine H2 receptor-mediated airway goblet cell secretion and its modulation by histamine-degrading enzymes.

Authors:  J Tamaoki; J Nakata; K Takeyama; A Chiyotani; K Konno
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

5.  Chemokines: leucocyte recruitment and activation cytokines.

Authors:  D H Adams; A R Lloyd
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

6.  Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.

Authors:  D G Kiely; R I Cargill; N M Wheeldon; W J Coutie; B J Lipworth
Journal:  Cardiovasc Res       Date:  1997-01       Impact factor: 10.787

7.  Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.

Authors:  D J Evans; P J Barnes; S M Spaethe; E L van Alstyne; M I Mitchell; B J O'Connor
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

8.  Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.

Authors:  R Anderson; A J Theron; C Feldman
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

9.  Efficacy of buspirone in smoking cessation: a placebo-controlled trial.

Authors:  N G Schneider; R E Olmstead; C Steinberg; K Sloan; R M Daims; H V Brown
Journal:  Clin Pharmacol Ther       Date:  1996-11       Impact factor: 6.875

10.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

Authors:  T C O'Shaughnessy; T W Ansari; N C Barnes; P K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405
View more
  9 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Theoretical models for the simulation of particle deposition and tracheobronchial clearance in lungs of patients with chronic bronchitis.

Authors:  Robert Sturm
Journal:  Ann Transl Med       Date:  2013-04

3.  Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD.

Authors:  H Sugiura; M Ichinose; S Yamagata; A Koarai; K Shirato; T Hattori
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

4.  Chronic obstructive pulmonary disease and weaning of difficult-to-wean patients from mechanical ventilation: randomized prospective study.

Authors:  Ivo Matić; Davorin Danić; Visnja Majerić-Kogler; Matija Jurjević; Ivan Mirković; Natalija Mrzljak Vucinić
Journal:  Croat Med J       Date:  2007-02       Impact factor: 1.351

Review 5.  Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.

Authors:  Katharine H Banner; Neil J Press
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

6.  Prospective Comparative Evaluation of Noninvasive and Invasive Mechanical Ventilation in Patients of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure Type II.

Authors:  Amartej Singh Sohal; Asha Anand; Prabhjot Kaur; Harpreet Kaur; Joginder Pal Attri
Journal:  Anesth Essays Res       Date:  2021-08-30

Review 7.  The history of COPD.

Authors:  Thomas L Petty
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 8.  Treating COPD with PDE 4 inhibitors.

Authors:  William M Brown
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 9.  Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease.

Authors:  Andrew J Thorley; Teresa D Tetley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.